Seer (NASDAQ:SEER) Trading Up 1.2% – Still a Buy?

Seer, Inc. (NASDAQ:SEER) was up 1.2% during trading on Friday . The company traded as high as $1.7250 and last traded at $1.72. Approximately 96,250 shares changed hands during mid-day trading, a decline of 53% from the average daily volume of 203,020 shares. The stock had previously closed at $1.70.

Analyst Ratings Changes

A number of equities research analysts recently commented on SEER shares. TD Cowen raised shares of Seer to a “strong-buy” rating in a research note on Monday, April 13th. Canaccord Genuity Group started coverage on shares of Seer in a research note on Monday, May 4th. They issued a “buy” rating and a $4.00 price objective on the stock. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Seer in a research note on Tuesday, April 21st. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Seer currently has an average rating of “Buy” and a consensus price target of $4.00.

Seer Stock Performance

The company has a market capitalization of $94.57 million, a PE ratio of -1.39 and a beta of 1.59. The stock’s fifty day simple moving average is $1.83 and its 200-day simple moving average is $1.85.

Seer (NASDAQ:SEER) last released its earnings results on Wednesday, May 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.30). The company had revenue of $2.79 million for the quarter, compared to analyst estimates of $3.60 million. Seer had a negative net margin of 464.78% and a negative return on equity of 26.58%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. NewEdge Advisors LLC purchased a new position in Seer in the 1st quarter valued at about $132,000. Rangeley Capital LLC lifted its holdings in Seer by 821.5% in the 1st quarter. Rangeley Capital LLC now owns 184,302 shares of the company’s stock valued at $310,000 after purchasing an additional 164,302 shares in the last quarter. Corient Private Wealth LLC purchased a new position in Seer in the 4th quarter valued at about $116,000. Quadrature Capital Ltd purchased a new position in Seer in the 4th quarter valued at about $101,000. Finally, Barclays PLC lifted its holdings in shares of Seer by 685.0% during the 4th quarter. Barclays PLC now owns 60,717 shares of the company’s stock worth $111,000 after acquiring an additional 52,982 shares during the period. 75.20% of the stock is currently owned by hedge funds and other institutional investors.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.